Streetbeat News

Products Services

BLNK

Blink Charging has partnered with Moberly Motor Company and Electric Era to bring fast and efficient DC charging to the dealership. This collaboration aims to provide a seamless charging experience for electric vehicle owners.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:16 pm

AVGO

Broadcom's shares are trading lower following a report by The Information suggesting that Google is considering dropping Broadcom as its AI chip supplier.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:13 pm

AAPL

WLDS

Wearable Devices Ltd. (NASDAQ:WLDS) announced that Apple's (NASDAQ:AAPL) new double tap feature, unveiled with the new Apple Series 9 Watch, is expected to enhance the utility and consumer experience of Wearable Devices' Mudra Band. The combination is expected to empower improved touchless control across the Apple product ecosystem, leveraging Wearable Devices' Air-Touch technology.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:10 pm

ETNB

89bio, Inc. (NASDAQ:ETNB) has announced that the U.S. FDA has granted Breakthrough Therapy Designation (BTD) to pegozafermin, a treatment for nonalcoholic steatohepatitis (NASH). The designation is supported by positive data from the ENLIVEN Phase 2b trial of pegozafermin. The company plans to discuss the NASH Phase 3 program with regulatory agencies in the fourth quarter of 2023.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:10 pm

CBAY

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) has initiated a Phase 3b/4 study, AFFIRM, to evaluate the effect of seladelpar on clinical outcomes in patients with cirrhosis due to primary biliary cholangitis (PBC). The study is designed to fulfill post-marketing requirements of the accelerated approval pathway for seladelpar. The study will enroll approximately 192 patients and will last for three years.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:08 pm

DARE

Daré Bioscience, Inc. (NASDAQ:DARE) will receive a payment of approximately $4.5 million as the latest installment under a grant agreement to advance the development of its investigational contraceptive DARE-LARC1. The total grant could reach up to $49 million. Daré received an initial $11.5 million payment in 2021 and aggregate payments of approximately $12.4 million in 2022. The company is also advancing the late-stage development of Ovaprene, a hormone-free monthly intravaginal contraceptive. Daré has a license agreement with Bayer for the development and commercialization of Ovaprene in the United States, if approved by the FDA.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:06 pm

HSCS

HeartSciences has signed definitive agreements with the Icahn School of Medicine at Mount Sinai to commercialize artificial intelligence cardiovascular algorithms. The deal could potentially boost HeartSciences' product portfolio and market presence.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:04 pm

NOVA

Sunnova and FranklinWH have launched a solar power battery designed for multi-family homes. The battery is the first 208V compatible product on the market and offers 13.6kWh of storage capacity. It also meets California's JA12 requirements. Sunnova provides 25-year service coverage for the product.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:03 pm

VEDU

Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) has announced plans to diversify its business into three sectors: Education, Life Sciences, and Artificial Intelligence. The company has also appointed Mr. Charlie Penn as Chief Operating Officer, effective from September 14, 2023. Mr. Penn has extensive experience in investment and education management.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:03 pm

NVCT

Nuvectis Pharma has announced upcoming presentations for its products NXP800 and NXP900. The company, which trades under the symbol NVCT, is expected to provide updates on these products.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:01 pm